Inhibitors of KAT2A Alleviate the Progression of AKI by Alleviating Macrophage Ferritinophagy
These findings demonstrate that KAT2A promotes AKI progression via NCOA4-mediated ferritinophagy and cGAS-STING inflammatory signaling in macrophages, highlighting KAT2A inhibition as a promising therapeutic strategy for AKI.
Authors
- ShengLan Gao
- Lawei Yang
- Zhenying Zuo
- Jiaxuan Chen (ORCID: https://orcid.org/0000-0003-3283-3085)
- Qingjun Pan
- Hongluan Wu
- Huafeng Liu
- Chen Yang
- Zhiliang Lu
- Zhongyu Liu
- Jinzheng Wang
- Xiaorong Hang
Institutions
- Guangdong Medical College (CN)
Publication Details
- Journal
- ImmunoTargets and Therapy
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/itt.s568586
- Primary Topic
- interferon and immune responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00